Related Experiment Video
Updated: Aug 6, 2026
Identifying the Effects of BRCA1 Mutations on Homologous Recombination using Cells that Express Endogenous Wild-type BRCA1
Published on: February 17, 2011
Somatic BRCA alterations in breast cancer are associated with distinct biological and clinical patterns according to
M Oshi1, K Kawashima1, M Sugimori2
1Department of Surgical Oncology, Roswell Park Comprehensive Cancer Center, Buffalo, USA; Department of Gastroenterological Surgery, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Background:
Comprehensive genomic profiling increasingly identifies BRCA alterations in breast cancer (BC). While germline BRCA mutations are well established as biologically and clinically relevant, the significance of somatic BRCA alterations remains unclear. We hypothesized that the implications of BRCA alterations may differ according to germline BRCA alterations.
Patients And Methods:
Among 5411 BC cases registered in the Center for Cancer Genomics and Advanced Therapeutics database, we analyzed 2978 BC cases with available germline (g) and somatic (s) BRCA status. Patients were categorized into four groups (g+/s+, g+/s-, g-/s+, and g-/s-). Mutational landscapes, homologous recombination deficiency (HRD)-related alterations, specimen origin, and time to treatment discontinuation (TTD) were evaluated, focusing on estrogen receptor (ER)-positive/HER2-negative and triple-negative breast cancer (TNBC).
Results:
g-/s+ tumors were more prevalent than g+/s+ tumors, and concordance between germline and somatic BRCA status was limited. Somatic BRCA alterations were more frequently detected in metastatic lesions and were more frequently observed in metastatic specimens. Genomically, g-/s+ tumors were enriched for oncogenic signaling mutations, including PIK3CA and TP53, whereas g+/s+ tumors showed HRD-related features dominated by BRCA alterations. Non-BRCA HRD-related alterations were most frequent in g-/s+ tumors (52%; P = 0.004). In ER-positive/HER2-negative BC, germline BRCA positivity was associated with shorter cyclin-dependent kinase 4 and 6 inhibitor TTD, and g+/s+ status remained independently associated with shorter TTD (hazard ratio 1.3, P < 0.001), whereas g-/s+ tumors were comparable with g-/s- tumors. In contrast, g-/s+ tumors showed TTD comparable with g-/s- tumors. In TNBC, immune checkpoint inhibitor outcomes were not associated with BRCA status.
Conclusions:
BRCA alteration groups defined by combined germline and somatic status showed distinct genomic and clinical patterns in BC. Somatic BRCA alterations should not be interpreted in isolation and require integration with germline status and broader genomic context.
More Related Videos
08:15gDNA Enrichment by a Transposase-based Technology for NGS Analysis of the Whole Sequence of BRCA1, BRCA2, and 9 Genes Involved in DNA Damage Repair
Published on: October 6, 2014
11:47Time-lapse Imaging of Primary Preneoplastic Mammary Epithelial Cells Derived from Genetically Engineered Mouse Models of Breast Cancer
Published on: February 8, 2013
Related Concept Videos
02:21Cancers Originate from Somatic Mutations in a Single Cell
02:21Cancers Originate from Somatic Mutations in a Single Cell
02:07Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
01:12Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
01:33Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...